Mass Device |
Report: IBM's Watson for Oncology not living up to “lofty expectations”
Mass Device After 3 years on the market, IBM's Watson for Oncology is not living up to the hype it's been sold under in its battle to find a cure for cancer, according to a new STAT report. So far, the system is still struggling to learn about different forms of ... IBM's Watson Supercomputer Was Supposed to Revolutionize Oncology. Things Aren't Going Great. A new advertising tack for hospitals: IBM's Watson supercomputer is in the house Experts say IBM Watson's flaws are rooted in data collection and interoperability |
from Health - Google News http://ift.tt/2w8fJkv
EmoticonEmoticon